PERRA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 197.146
NA - Nord America 6.846
AS - Asia 2.717
SA - Sud America 464
AF - Africa 84
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 207.281
Nazione #
IT - Italia 195.135
US - Stati Uniti d'America 6.721
CN - Cina 1.136
SG - Singapore 941
SE - Svezia 505
DE - Germania 450
BR - Brasile 381
UA - Ucraina 316
FI - Finlandia 194
GB - Regno Unito 182
VN - Vietnam 170
CA - Canada 87
FR - Francia 83
KR - Corea 78
HK - Hong Kong 75
TR - Turchia 56
IN - India 49
NL - Olanda 42
PL - Polonia 40
BE - Belgio 36
MA - Marocco 36
JP - Giappone 35
ZA - Sudafrica 33
AR - Argentina 30
RU - Federazione Russa 29
ID - Indonesia 28
ES - Italia 26
MX - Messico 26
AT - Austria 24
BD - Bangladesh 23
IR - Iran 20
AU - Australia 19
LT - Lituania 14
EC - Ecuador 13
PK - Pakistan 13
IE - Irlanda 12
CO - Colombia 11
MY - Malesia 10
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
IL - Israele 8
IQ - Iraq 8
PE - Perù 8
SA - Arabia Saudita 8
TH - Thailandia 8
CH - Svizzera 7
CL - Cile 7
UZ - Uzbekistan 7
DK - Danimarca 6
LK - Sri Lanka 5
MT - Malta 5
PA - Panama 5
TW - Taiwan 5
BG - Bulgaria 4
EU - Europa 4
KE - Kenya 4
PT - Portogallo 4
AL - Albania 3
AZ - Azerbaigian 3
DZ - Algeria 3
GR - Grecia 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MV - Maldive 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 207.272
Città #
Cagliari 190.893
Uta 3.615
Ashburn 775
Fairfield 611
Dallas 507
Singapore 463
Chandler 412
Woodbridge 395
Houston 334
Nyköping 331
Boardman 296
Ann Arbor 261
Beijing 252
Wilmington 246
Seattle 210
Cambridge 196
Los Angeles 186
Jacksonville 159
Dearborn 156
Munich 149
New York 112
Santa Clara 109
Shanghai 107
Helsinki 106
Hefei 98
Seoul 75
The Dalles 73
Hong Kong 72
Boston 60
Nanjing 60
Rome 50
Buffalo 47
Dong Ket 46
Guangzhou 44
Milan 43
Redwood City 43
San Diego 43
São Paulo 43
Chicago 40
London 37
Ho Chi Minh City 36
Redondo Beach 35
Toronto 35
Brussels 34
Warsaw 34
Turku 33
Casablanca 32
Kocaeli 29
San Mateo 29
Montreal 28
Frankfurt am Main 27
Atlanta 26
Brooklyn 26
Falls Church 26
Denver 25
Nanchang 25
Stockholm 24
Tokyo 24
Johannesburg 23
Nuremberg 23
Hanoi 22
Jiaxing 21
Shenyang 20
Chennai 19
Mountain View 19
Düsseldorf 18
Phoenix 18
Shenzhen 18
Council Bluffs 17
Minneapolis 16
Rio de Janeiro 16
Jinan 15
Tianjin 15
Augusta 14
Changsha 14
Leawood 14
Poplar 14
Washington 14
Amsterdam 13
Ankara 13
Vienna 13
Manchester 12
Norwalk 12
Sassari 12
Bari 11
Columbus 11
Salt Lake City 11
Verona 11
Wuhan 11
Curitiba 10
Hebei 10
Mexico City 10
Paris 10
Zhengzhou 10
Belo Horizonte 9
Biên Hòa 9
Dublin 9
Orange 9
Orem 9
Pisa 9
Totale 202.867
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.962
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.738
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.931
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.212
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.194
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.981
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.909
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.815
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.697
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.663
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.658
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.609
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.547
Global gene expression profile of normal and regenerating liver in young and old mice 3.518
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.422
Induction of hepatocyte proliferation by retinoic acid 3.274
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.224
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.123
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.108
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.084
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.020
THYROID HORMONE RECEPTORS DOWNREGULATION IS AN EARLY EVENT AND IS MAINTAINED ALLACROSS THE STEP-BY-STEP PROCESS OF HEPATOCARCINOGENESIS 2.937
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.921
Wnt/beta-catenin pathway is activated by thyroid hormone and is required for its hepatomitogenic activity 2.919
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.874
ALFA-LIPOIC ACID ENHANCES CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER AND STEATOHEPATITIS, AND PROMOTES THE GROWTH OF PRENEOPLASTIC LESIONS IN RAT LIVER. POSTER EASL 2.861
Thyroid hormone receptors downregulation is an early event and is maintained all across the step-by-step process of hepatocarcinogenesis. 2.765
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.742
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.733
Progenitor-derived hepatocellular carcinoma model in the rat 2.692
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.689
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.604
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.600
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.599
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.537
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.505
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.470
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.429
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 2.408
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.400
null 2.399
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.374
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.354
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.351
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.287
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.159
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.084
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.959
Cytokeratin-19, a predictive marker and an early determinant of progenitor-derived hepatocellular carcinoma 1.957
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.870
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.749
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.725
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.621
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.606
Early metabolic changes in a liver carcinogenesis model 1.467
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.412
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.387
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.287
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.235
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.173
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.161
Early Metabolic Changes in preneoplastc nodules of the liver 1.135
Hepatic stellate cell: a star cell in the liver 1.078
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.017
Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females 1.001
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 907
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 906
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 862
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 841
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 839
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 823
Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa 785
Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19 775
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 774
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 762
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 697
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 687
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity 669
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 642
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 637
Inhibitory effect of thyroid hormone (T3) on the development of rat hepatocellular carcinoma. POSTER 615
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 567
Morphological alterations of the lung in the Sickle Cell Trait 549
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration 514
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 474
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 467
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 455
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 435
Analysis of pathological findings in a humanized murine model of sickle cell anemia 427
Alpha lipoic acid promotes preneoplastic growth in rat liver. POSTER 23° Meeting of German Association for the Study of Liver (GASL), Gottingen 422
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 420
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 407
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 393
Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders 380
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 375
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 375
Morphological investigation of endothelial and sub-endothelial alterations associated with sickle cell trait in a mouse model 370
Electron microscopy investigation of the Townes mouse spleen: an example of Translational Anatomy 343
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 302
Totale 206.309
Categoria #
all - tutte 248.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.859 0 0 0 0 0 4.664 2.908 2.740 1.336 2.419 2.441 1.351
2021/202210.543 1.481 750 419 752 937 661 455 434 1.189 1.105 1.233 1.127
2022/202316.318 1.073 2.121 2.240 1.383 1.260 1.700 902 940 1.116 1.236 1.499 848
2023/202416.202 1.026 678 893 923 1.442 2.416 2.610 1.407 687 990 1.364 1.766
2024/202537.531 11.399 12.112 3.543 3.185 1.523 1.947 2.254 207 332 297 318 414
2025/20264.006 661 513 986 894 891 61 0 0 0 0 0 0
Totale 207.676